First-line treatment for non-small cell lung cancer

被引：0
|
作者：
Pinn, Stephen
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2011年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [41] Dacomitinib as first-line treatment for EGFR mutation-positive non-small cell lung cancer
    Reungwetwattana, Thanyanan
    Rohatgi, Nitesh
    Mok, Tony S.
    Prabhash, Kumar
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (03): : 161 - 171
  • [42] First-Line Systemic Chemotherapy in the Treatment of Advanced Non-small Cell Lung Cancer A Systematic Review
    Goffin, John
    Lacchetti, Christina
    Ellis, Peter M.
    Ung, Yee C.
    Evans, William K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 260 - 274
  • [43] Platinum doublets as first-line treatment for elderly patients with advanced non-small cell lung cancer
    Piacentini, Paolo
    Greco, Filippo
    Mercanti, Anna
    Trolese, Anna Rita
    Durante, Emilia
    Moratello, Giacomo
    Tognetto, Michele
    Furini, Lara
    Giuliani, Jacopo
    Bonetti, Andrea
    TUMORI JOURNAL, 2013, 99 (06): : 650 - 655
  • [44] Hypoalbuminaemia as a Prognostic Biomarker of First-Line Treatment Resistance in Metastatic Non-small Cell Lung Cancer
    Stares, Mark
    Swan, Amanda
    Cumming, Kirsten
    Ding, Tze-En
    Leach, James
    Stratton, Cory
    Thomson, Findlay
    Barrie, Colin
    MacLennan, Kirsty
    Campbell, Sorcha
    Evans, Tamasin
    Tufail, Aisha
    Harrow, Stephen
    MacKean, Melanie
    Phillips, Iain
    FRONTIERS IN NUTRITION, 2021, 8
  • [45] Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
    Kaya, Ali Osman
    Buyukberber, Suleyman
    Dane, Faysal
    Isikdogan, Abdurrahman
    Ustaalioglu, Basak Oven
    Coskun, Ugur
    Yumuk, Perran Fulden
    Dogu, Gamze Gokoz
    Ozdemir, Nuriye Yildirim
    Sevinc, Alper
    Gumus, Mahmut
    Ozkan, Metin
    Yildiz, Ramazan
    Ozturk, Banu
    Yaman, Emel
    Benekli, Mustafa
    TUMORI JOURNAL, 2010, 96 (03): : 400 - 404
  • [46] Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience
    Ricciuti, Biagio
    Baglivo, Sara
    De Giglio, Andrea
    Chiari, Rita
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [47] Immunotherapy as first-line treatment in metastatic non-small cell lung cancer: A single center experience
    Rauthan, A.
    Patil, P.
    Lahkar, K.
    Murthy, N. Y.
    Vundemodalu, P.
    Ashwath, R.
    Jomi, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S1576 - S1576
  • [48] Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation
    Han, Kelong
    Claret, Laurent
    Sandler, Alan
    Das, Asha
    Jin, Jin
    Bruno, Rene
    BMC CANCER, 2016, 16
  • [49] Erlotinib in the first-line treatment of non-small-cell lung cancer
    D'Arcangelo, Manolo
    Cappuzzo, Federico
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (05) : 523 - 533
  • [50] First-line treatment for advanced non-small-cell lung cancer
    Laskin, Janessa J.
    Sandler, Alan B.
    ONCOLOGY-NEW YORK, 2005, 19 (13): : 1671 - 1676
12345